
Press Release|Articles|April 29, 2025
Camber Pharmaceuticals Launches Chlorzoxazone Tablets, USP
Listen
0:00 / 0:00
Key Takeaways
- Chlorzoxazone Tablets, USP, target relief from acute, painful musculoskeletal conditions as an adjunct therapy.
- The tablets are intended to complement rest, physical therapy, and other treatment measures.
Advertisement
Camber Pharmaceuticals is excited to announce the addition of Chlorzoxazone Tablets, USP.
Chlorzoxazone Tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.
Chlorzoxazone 250 mg Tablets, USP are available in 60 count bottles.
To find out more information on Chlorzoxazone Tablets, USP, please visit:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
2
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
3
Pharmacist Spotlight: Kelly Gable, PharmD, BCPP, FAAPP
4
Advancing Precision Oncology: Pharmacist Perspectives on MRD Testing and Diagnostic Innovation
5
















































































































































































































